Breakwater Capital Group Purchases 440 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Breakwater Capital Group lifted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 18.0% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,890 shares of the healthcare conglomerate’s stock after purchasing an additional 440 shares during the period. Breakwater Capital Group’s holdings in UnitedHealth Group were worth $1,514,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also added to or reduced their stakes in the company. NewSquare Capital LLC acquired a new stake in UnitedHealth Group during the 4th quarter worth about $25,000. Marshall & Sterling Wealth Advisors Inc. acquired a new stake in UnitedHealth Group during the fourth quarter worth approximately $26,000. Hurley Capital LLC acquired a new position in UnitedHealth Group in the fourth quarter valued at approximately $28,000. Aster Capital Management DIFC Ltd acquired a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $30,000. Finally, Promus Capital LLC acquired a new stake in UnitedHealth Group in the fourth quarter worth $32,000. Institutional investors own 87.86% of the company’s stock.

Insider Activity

In other news, Director Timothy Patrick Flynn acquired 1,533 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, May 14th. The stock was purchased at an average cost of $320.80 per share, with a total value of $491,786.40. Following the completion of the acquisition, the director now owns 6,033 shares in the company, valued at $1,935,386.40. This trade represents a 34.07% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Stephen J. Hemsley purchased 86,700 shares of the company’s stock in a transaction dated Friday, May 16th. The stock was purchased at an average price of $288.57 per share, with a total value of $25,019,019.00. Following the transaction, the chief executive officer now owns 679,493 shares of the company’s stock, valued at approximately $196,081,295.01. This represents a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last 90 days, insiders have purchased 109,408 shares of company stock valued at $31,607,768. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Trading Down 0.3%

UNH opened at $300.37 on Thursday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The stock has a market capitalization of $272.48 billion, a PE ratio of 19.38, a P/E/G ratio of 1.37 and a beta of 0.56. UnitedHealth Group Incorporated has a one year low of $248.88 and a one year high of $630.73. The business’s 50 day moving average price is $418.00 and its 200 day moving average price is $488.12.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). The firm had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same quarter in the previous year, the business posted $6.91 earnings per share. As a group, equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on UNH. Deutsche Bank Aktiengesellschaft decreased their target price on shares of UnitedHealth Group from $521.00 to $362.00 and set a “buy” rating for the company in a research report on Wednesday, May 14th. Oppenheimer lowered their price objective on UnitedHealth Group from $600.00 to $400.00 and set an “outperform” rating for the company in a research note on Wednesday, May 14th. HSBC reiterated a “reduce” rating and set a $270.00 price target (down previously from $490.00) on shares of UnitedHealth Group in a report on Wednesday, May 21st. Wolfe Research cut their price objective on shares of UnitedHealth Group from $501.00 to $390.00 and set an “outperform” rating on the stock in a report on Tuesday, May 20th. Finally, Morgan Stanley dropped their price target on shares of UnitedHealth Group from $563.00 to $374.00 and set an “overweight” rating on the stock in a research report on Wednesday, May 14th. One research analyst has rated the stock with a sell rating, seven have given a hold rating and seventeen have given a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $428.43.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.